What does APOTHEEK SINT BAVO do?

APOTHEEK SINT BAVO is a pharmacy in Boechout. Private Limited, started on 27 March 1997, 1 establishment.

What is the address of APOTHEEK SINT BAVO?

The registered office of APOTHEEK SINT BAVO is located at Heuvelstraat 100, 2530 Boechout.

Is APOTHEEK SINT BAVO still active?

Yes. According to the CBE (30 October 2026) APOTHEEK SINT BAVO is active, legal situation “Normale toestand”, started on 27 March 1997.

Is APOTHEEK SINT BAVO registered on Peppol?

Yes, APOTHEEK SINT BAVO is registered on the Peppol network with ID 0208:0460304194.

What is the enterprise number of APOTHEEK SINT BAVO?

The enterprise number of APOTHEEK SINT BAVO is BE0460304194.

When was APOTHEEK SINT BAVO founded?

APOTHEEK SINT BAVO was founded on 27 March 1997.

Who are the directors of APOTHEEK SINT BAVO?

According to the 2025 annual accounts, the directors of APOTHEEK SINT BAVO are: Libra Pharma BV.

Is APOTHEEK SINT BAVO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 March 1997; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK SINT BAVO make in 2025?

APOTHEEK SINT BAVO recorded a loss after taxes of € 20,076 in financial year 2025.

What is the revenue of APOTHEEK SINT BAVO?

As a small company, APOTHEEK SINT BAVO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 194,671.

How much does an employee at APOTHEEK SINT BAVO earn?

The average wage cost per full-time employee at APOTHEEK SINT BAVO was € 72,400 in 2025: staff costs of € 202,808 for 2.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK SINT BAVO have?

According to the 2025 annual accounts, APOTHEEK SINT BAVO has 2.8 full-time equivalents (FTE).

Does APOTHEEK SINT BAVO have a website?

Yes, APOTHEEK SINT BAVO has a website at apotheeksintbavo.be.

APOTHEEK SINT BAVO (Private Limited) - Boechout

Dossier APOTHEEK SINT BAVO, printed on 30 October 2026 from databakkes.be/en/0460304194/apotheek-sint-bavo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 3.8 to 2.8.

Financials

Financial year 2025

APOTHEEK SINT BAVO from Boechout, company number BE0460304194, closed financial year 2025 with a result of € -20,076 after tax. For that financial year APOTHEEK SINT BAVO recorded a gross margin of € 194,671 and equity of € 401,080. Compared with financial year 2024, the result moved from € 22,355 to € -20,076. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Healthy

€ 401,080

▼ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -20,076

▼ still € 22,355 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 89,757

▼ 36% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 394,475.

People and assets in 2025

Full-time equivalents

2.8

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 202,808

▼ 8% vs 2024

€ 72,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,405

▲ 67% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 198,955

▲ 64% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,510

▼ 27% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 320,828 Gross margin 2022: € 320,828 First fiscal year in the series	€ 333,501 Gross margin 2023: € 333,501 ▲ 4% vs 2022 (€ 320,828) Favourable step	€ 271,330 Gross margin 2024: € 271,330 ▼ 19% vs 2023 (€ 333,501) Unfavourable step	€ 194,671 Gross margin 2025: € 194,671 ▼ 28% vs 2024 (€ 271,330) Unfavourable step	▼ 28%
Profit after taxes	€ 54,830 Profit after taxes 2022: € 54,830 First fiscal year in the series	€ 24,133 Profit after taxes 2023: € 24,133 ▼ 56% vs 2022 (€ 54,830) Unfavourable step	€ 22,355 Profit after taxes 2024: € 22,355 ▼ 7% vs 2023 (€ 24,133) Unfavourable step	€ -20,076 Profit after taxes 2025: € -20,076 ▼ € 42,431 vs 2024 (€ 22,355) Unfavourable step	▼ € 42,431
Equity	€ 389,667 Equity 2022: € 389,667 First fiscal year in the series	€ 398,801 Equity 2023: € 398,801 ▲ 2% vs 2022 (€ 389,667) Favourable step	€ 421,156 Equity 2024: € 421,156 ▲ 6% vs 2023 (€ 398,801) Favourable step	€ 401,080 Equity 2025: € 401,080 ▼ 5% vs 2024 (€ 421,156) Unfavourable step	▼ 5%
Total debts	€ 196,509 Total debts 2022: € 196,509 First fiscal year in the series	€ 200,310 Total debts 2023: € 200,310 ▲ 2% vs 2022 (€ 196,509) Unfavourable step	€ 160,754 Total debts 2024: € 160,754 ▼ 20% vs 2023 (€ 200,310) Favourable step	€ 277,111 Total debts 2025: € 277,111 ▲ 72% vs 2024 (€ 160,754) Unfavourable step	▲ 72%
Cash	€ 209,471 Cash 2022: € 209,471 First fiscal year in the series	€ 178,569 Cash 2023: € 178,569 ▼ 15% vs 2022 (€ 209,471) Unfavourable step	€ 139,682 Cash 2024: € 139,682 ▼ 22% vs 2023 (€ 178,569) Unfavourable step	€ 89,757 Cash 2025: € 89,757 ▼ 36% vs 2024 (€ 139,682) Unfavourable step	▼ 36%
Land & buildings	€ 33,278 Land & buildings 2022: € 33,278 First fiscal year in the series	€ 27,439 Land & buildings 2023: € 27,439 ▼ 18% vs 2022 (€ 33,278) Unchanged	-	-
Retained profit	€ 383,062 Retained profit 2022: € 383,062 First fiscal year in the series	€ 392,195 Retained profit 2023: € 392,195 ▲ 2% vs 2022 (€ 383,062) Favourable step	€ 414,550 Retained profit 2024: € 414,550 ▲ 6% vs 2023 (€ 392,195) Favourable step	€ 394,475 Retained profit 2025: € 394,475 ▼ 5% vs 2024 (€ 414,550) Unfavourable step	▼ 5%
Dividend	€ 45,000 Dividend 2022: € 45,000 First fiscal year in the series	€ 15,000 Dividend 2023: € 15,000 ▼ 67% vs 2022 (€ 45,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 15,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 586,176 Balance sheet total 2022: € 586,176 First fiscal year in the series	€ 599,111 Balance sheet total 2023: € 599,111 ▲ 2% vs 2022 (€ 586,176) Unchanged	€ 581,909 Balance sheet total 2024: € 581,909 ▼ 3% vs 2023 (€ 599,111) Unchanged	€ 678,191 Balance sheet total 2025: € 678,191 ▲ 17% vs 2024 (€ 581,909) Unchanged	▲ 17%
Employees (FTE)	4 Employees (FTE) 2022: 4 First fiscal year in the series	3.8 Employees (FTE) 2023: 3.8 ▼ 0.2 vs 2022 (4) Unchanged	3.2 Employees (FTE) 2024: 3.2 ▼ 0.6 vs 2023 (3.8) Unchanged	2.8 Employees (FTE) 2025: 2.8 ▼ 0.4 vs 2024 (3.2) Unchanged	▼ 0.4

Key figures of APOTHEEK SINT BAVO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK SINT BAVO?

What happened at APOTHEEK SINT BAVO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: loss of € 20,076 (▼ € 42,431 vs 2024). Source: NBB ↗
2025 Libra Pharma BV became a director. NBB
May 30, 1997 New establishment in Boechout. KBO
Mar 27, 1997 Start of the company according to the CBE. KBO

In short

From € 54,830 profit in 2022 to € 20,076 loss in 2025.

Paid € 20,009 in corporate taxes since 2022.

Best year ever: 2022, with € 54,830 profit.

On average € 69,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DCV PHARMA 100%

LIBRA PHARMA 100%

The stake of DCV PHARMA, LIBRA PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK SINT BAVO

Behind APOTHEEK SINT BAVO is Libra Pharma BV. The shares are held by DCV PHARMA (100%) and LIBRA PHARMA (100%).

Directors

According to the 2025 annual accounts

Libra Pharma BV

Director · represented by Esmoreit De Neef

Also active at: BYTEBIER KAATJE

since 2025

Shareholders

DCV PHARMA

100%

LIBRA PHARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Heuvelstraat 100

2530 Boechout

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheeksintbavo.be

Technologies

AMPAdobe FontsAlpine.jsCookie ConsentGoogle FontsGoogle TranslateNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

UPCLOUD, FI

Website info

HTTPS Ja

Indexable pages 53,085

Languages NL

Features

Webshop Newsletter

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

Details

Company number

0460.304.194

VAT number

BE 0460.304.194

Registered office

Heuvelstraat 100, 2530 Boechout

Names & denominations

APOTHEEK SINT BAVO

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 March 1997

Peppol

Active · Active since 26 Sept 2026

Contact

apotheeksintbavo.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK SINT BAVO

Warning lights

Financials

What happened to APOTHEEK SINT BAVO?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions